Bucarium Chlorambucil Tablets IP 2 mg is a prescription oral oncology medicine identified as containing Chlorambucil 2 mg per tablet.

Chlorambucil is a cytotoxic anticancer medicine classified as a nitrogen mustard alkylating agent.

It damages DNA through alkylation and cross-link formation, interfering with the replication and survival of rapidly dividing cells.

Chlorambucil has established uses in selected treatment settings for chronic lymphocytic leukemia (CLL), Hodgkin lymphoma and certain non-Hodgkin lymphomas.

Its role in modern treatment depends on disease characteristics, patient factors, availability of alternative therapies and specialist guidance.

The stated 2 mg tablet strength does not establish the prescribed daily dose. Dosing varies according to the disease, treatment schedule, blood counts and patient condition.

The exact manufacturer, pack size, tablet composition, storage conditions and approved indications of Bucarium must be verified from its approved Indian product documentation.

The product name includes IP (Indian Pharmacopoeia). Compliance with the applicable pharmacopoeial standard must be supported by manufacturer documentation.

Marketed by Essentials Emporium Enterprises, Bucarium is listed within the oncology pharmaceutical category for hospitals, cancer treatment centres and authorized pharmaceutical buyers.

Key Product Features